Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
How many ships have been attacked in the Gulf since start of Iran war? - 2Trump said affordability is a ‘hoax’ in his Pennsylvania speech. What do the latest numbers show?
- 3Netanyahu vows to ‘return Negev to Israel,’ pledges settlement growth during visit
- 4Wizz CEO: We’re going to invest $1 b. in Israeli market
- 5Manual for Picking Coastline Travel
- Vote in favor of your Number one Kind of Gems
- He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- Vote in favor of your Number one Kind of Shades
- Fundamental Monetary Guidance for Going into Business
- Surging measles cases are 'fire alarm' warning that other diseases could be next
- Senegal president signs tough new anti-LGBT law doubling jail terms
- Triple polar vortex to plunge central and eastern U.S. into Arctic cold through mid-December
- As juries turn against social media for harming kids, Big Tech's invincibility starts to show cracks
- New movies to watch this weekend: See 'Predator: Badlands' in theaters, rent 'Black Phone 2,' stream Guillermo del Toro's 'Frankenstein' on Netflix
